CAMBRIDGE, Mass.–(BUSINESS WIRE)–$sage #SageRx–Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 12, 2019 at 8:00 a.m. EST to report its third quarter 2019 financial results and … [Read more…]
GAINESVILLE, Fla.–(BUSINESS WIRE)–#ConceptCompanies—Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has announced commencement of construction on a new office and lab building in Copeland Park for Lacerta Therapeutics, a clinical-stage gene therapy company. The 12,950 square foot building is expected to be completed in the Spring of 2020. Strategically located in … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biomedical Temperature Sensors – Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering. The Global Biomedical Temperature Sensors market accounted for $5.6 billion in 2017 and is expected to reach $10.1 billion by 2026 growing at a CAGR of 6.8% during the forecast period. Some of the key factors influencing the … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Diabetes Management: Insulin Pumps Market (2019)” report has been added to ResearchAndMarkets.com’s offering. The Global Insulin Pumps market is being driven by strong demand, increasing awareness and adoption of next-generation hybrid closed-loop systems, solid clinical outcomes, and good reimbursement. Market penetration is low, leaving much room for growth. According to the International Diabetes … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–#biotech—Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of seasoned biotech executive, George Ng, Partner of PENG Life Science Ventures. His extensive background includes co-founding and leading the efforts of a pharmaceutical company from pre-clinical to clinical to New Drug … [Read more…]
LONDON–(BUSINESS WIRE)–#ArcherDanielsMidlandCompany–Technavio has been monitoring the global superfoods market since 2016 and the market is poised to grow by USD 201.67 billion during 2019-2023, progressing at a CAGR of 17% during the forecast period. Request Free Sample Pages Read the 114-page research report with TOC on “Superfoods Market Analysis Report by Product (superfruits, superseeds and … [Read more…]
New facility will be a major research and development hub for molecular spectroscopy SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies, Inc. (NYSE: A) today announced the opening of a new state-of-the-art facility for spectroscopy research and development at the Harwell Science and Innovation Campus in Oxfordshire, UK. A leader in molecular spectroscopy, the new Agilent site will … [Read more…]
ESPOO, Finland–(BUSINESS WIRE)–#AMR–Mobidiag Ltd., a revenue generating, molecular diagnostics company with complementary platforms that address antimicrobial resistance and other areas of unmet diagnostic need, today announces the CE-IVD marking of the Novodiag® Stool Parasites test, a comprehensive and cost-effective molecular diagnostic test for the detection of intestinal parasites directly from stool samples. Tuomas Tenkanen, CEO … [Read more…]
Data will communicate new and updated findings, including in the treatment of psoriasis, atopic dermatitis and chronic hand eczema BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma A/S, a global leader in medical dermatology, today announced that data from company-sponsored, health economic outcome and investigator-initiated studies will be presented at the 28th annual Congress of the European Academy of … [Read more…]
Real-world data from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) shows that BENEPALI™ is effective in patients with psoriasis INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. today announced real-world data of BENEPALI™ in patients with moderate to severe psoriasis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). The results … [Read more…]
